semaglutide after kidney transplant GLP-1 Agonism for Recipients: A Narrative Review of Current Evidence and Future Directions Across the Research Spectrum Obesity management for kidney TRANSPLANTation

Less common side effects include: low heart rate, heart rate abnormalities, swelling, heart failure, high blood pressure, heart rupture (after recent heart attack), fainting, tachycardia, acne, allergic dermatitis, bruising, dry skin, decreased serum potassium, weight gain, hiccups, increased appetite, nausea, anaphylaxis, angioedema, non-immune anaphylaxis, euphoria, headache, neuropathy, paresthesia, personality changes, seizure, vertigo, tendon rupture, impaired wound healing

Encontre o que procura

Each formulation presents distinct analytical testing challenges

When used for metabolic support, it is prescribed off-label based on a patients medical history, lab findings, and provider judgment

Bearing in mind that a recent review stated that nonalcoholic fatty liver disease (NAFLD) is very frequent in PCOS patients, and that the combination of PCOS with obesity and IR is a dangerous cocktail that, over time, triggers not only NALFD but also the occurrence of type II diabetes (40, 41), as an additional feature, we also evaluated the HIE in our patients (23)